Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.9523
+0.0024 (0.25%)
May 15, 2026, 4:00 PM EDT - Market closed

ZYBT Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
116.36186.36211.65260.27214.07
Revenue Growth (YoY)
-37.56%-11.95%-18.68%21.58%-
Cost of Revenue
92.4995.0694.14112.3988.67
Gross Profit
23.8791.3117.51147.88125.39
Selling, General & Admin
74.9263.8464.3458.8958.19
Research & Development
18.0112.7911.913.4211.37
Other Operating Expenses
1.44-1.78-3.719.743.45
Total Operating Expenses
94.3874.8672.5282.0573.01
Operating Income
-70.5116.4444.9965.8352.38
Interest Income
0.10.230.310.110.11
Interest Expense
-3.4-4.04-4.42-2.84-1.05
Other Non-Operating Income (Expense)
1.941.772.890.811.62
Total Non-Operating Income (Expense)
-1.37-2.05-1.22-1.920.68
Pretax Income
-71.8714.3943.7663.9153.07
Provision for Income Taxes
11.10.926.258.176.6
Net Income
-69.7811.3131.4646.7446.47
Net Income to Common
-69.7811.3131.4646.7446.47
Net Income Growth
--64.04%-32.69%0.58%-
Shares Outstanding (Basic)
4746464646
Shares Outstanding (Diluted)
4746464646
Shares Change (YoY)
3.69%----
EPS (Basic)
-1.470.250.691.021.02
EPS (Diluted)
-1.470.250.691.021.02
EPS Growth
--63.77%-32.35%0.25%-
Shares Outstanding
47.3945.6745.67--
Free Cash Flow
12.3327.4640.79-9.9912.75
Free Cash Flow Growth
-55.12%-32.68%---
Free Cash Flow Per Share
0.260.600.89-0.220.28
Gross Margin
20.51%48.99%55.52%56.82%58.58%
Operating Margin
-60.59%8.82%21.25%25.29%24.47%
Profit Margin
-71.30%7.23%17.72%21.42%21.71%
FCF Margin
10.59%14.73%19.27%-3.84%5.95%
EBITDA
-44.6240.668.984.6368.4
EBITDA Margin
-38.35%21.79%32.55%32.52%31.95%
EBIT
-70.5116.4444.9965.8352.38
EBIT Margin
-60.59%8.82%21.25%25.29%24.47%
Effective Tax Rate
-15.44%6.42%14.29%12.79%12.44%
Updated Apr 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q